• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/198

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

198 Cards in this Set

  • Front
  • Back
ACM - 10
Appropriate Care Measures - 10
ACM - Complete
Appropriate Care Measures - Complete
ACM - Total
Appropriate Care Measures - Total
AMI - 1
Aspirin at arrival
AMI - 10
Statin Prescribed at Discharge
AMI - 2
Aspirin prescribed at discharge
AMI - 3
ACEI or ARB for LVSD
AMI - 5
Beta blocker prescribed at discharge
AMI - 7
Reperfusion therapy - Median time from arrival to initiation of fibrinolytic medication administration
AMI - 7a
Fibrinolytic Therapy Agent Received Within 30 Minutes of Hospital Arrival
AMI - 8
Reperfusion therapy - Median time from arrival to initiation of primary percutaneous transluminal coronary angioplasty
AMI - 8a
PCI received within 90 minutes of hospital arrival
CAC - 1a
Relievers for Inpatient Asthma (age 2 years through 17 years) - Overall Rate
CAC - 1b
Relievers for Inpatient Asthma (age 2 years through 4 years)
CAC - 1c
Relievers for Inpatient Asthma (age 5 years through 12 years)
CAC - 1d
Relievers for Inpatient Asthma (age 13 through 17 years)
CAC - 2a
Systemic Corticosteroids for Inpatient Asthma (age 2 years through 17 years) - Overall Rate
CAC - 2b
Systemic Corticosteroids for Inpatient Asthma (age 2 years through 4 years)
CAC - 2c
Systemic Corticosteroids for Inpatient Asthma (age 5 years through 12 years)
CAC - 2d
Systemic Corticosteroids for Inpatient Asthma (age 13 years through 17 years)
CAC - 3
Home Management Plan of Care (HMPC) Document Given to Patient/Caregiver
ED-1a
Median Time from ED Arrival to ED Departure for Admitted ED Patients - Overall Rate
ED-1b
Median Time from ED Arrival to ED Departure for Admitted ED Patients - Reporting Measure
ED-1c
Median Time from ED Arrival to ED Departure for Admitted ED Patients - Observation Patients
ED-1d
Median Time from ED Arrival to ED Departure for Admitted ED Patients - Psychiatric/Mental Health Patients
ED-2a
Admit Decision Time to ED Departure Time for Admitted Patients - Overall Rate
ED-2b
Admit Decision Time to ED Departure Time for Admitted Patients - Reporting Measure
ED-2c
Admit Decision Time to ED Departure Time for Admitted Patients -Psychiatric/Mental Health Patients
HBIPS-1a
Admission Screening- Overall Rate
HBIPS-1b
Admission Screening- Children (1 through 12 years)
HBIPS-1c
Admission Screening- Adolescent (13 through 17 years)
HBIPS-1d
Admission Screening- Adult (18 through 64 years)
HBIPS-1e
Admission Screening- Older Adult (>=65 years)
HBIPS-2a
Physical Restraint- Overall Rate
HBIPS-2b
Physical Restraint- Children (1 through 12 years)
HBIPS-2c
Physical Restraint- Adolescent (13 through 17 years)
HBIPS-2d
Physical Restraint- Adult (18 through 64 years)
HBIPS-2e
Physical Restraint- Older Adult (>=65 years)
HBIPS-3a
Seclusion- Overall Rate
HBIPS-3b
Seclusion- Children (1 through 12 years)
HBIPS-3c
Seclusion- Adolescent (13 through 17 years)
HBIPS-3d
Seclusion- Adult (18 through 64 years)
HBIPS-3e
Seclusion- Older Adult (>=65 years)
HBIPS-4a
Multiple Antipsychotic Medications at Discharge- Overall Rate
HBIPS-4b
Multiple Antipsychotic Medications at Discharge- Children (1 through 12 years)
HBIPS-4c
Multiple Antipsychotic Medications at Discharge- Adolescent (13 through 17 years)
HBIPS-4d
Multiple Antipsychotic Medications at Discharge- Adult (18 through 64 years)
HBIPS-4e
Multiple Antipsychotic Medications at Discharge- Older Adult (>=65 years)
HBIPS-5a
Multiple Antipsychotic Medications at Discharge with Appropriate Justification- Overall Rate
HBIPS-5b
Multiple Antipsychotic Medications at Discharge with Appropriate Justification- Children (1 through 12 years)
HBIPS-5c
Multiple Antipsychotic Medications at Discharge with Appropriate Justification- Adolescent (13 through 17 years)
HBIPS-5d
Multiple Antipsychotic Medications at Discharge with Appropriate Justification- Adult (18 through 64 years)
HBIPS-5e
Multiple Antipsychotic Medications at Discharge with Appropriate Justification- Older Adult (>=65 years)
HBIPS-6a
Post Discharge Continuing Care Plan- Overall Rate
HBIPS-6b
Post Discharge Continuing Care Plan- Children (1 through 12 years)
HBIPS-6c
Post Discharge Continuing Care Plan- Adolescent (13 through 17 years)
HBIPS-6d
Post Discharge Continuing Care Plan- Adult (18 through 64 years)
HBIPS-6e
Post Discharge Continuing Care Plan- Older Adult (>=65 years)
HBIPS-7a
Post Discharge Continuing Care Plan Transmitted- Overall Rate
HBIPS-7b
Post Discharge Continuing Care Plan Transmitted - Children (1 through 12 years)
HBIPS-7c
Post Discharge Continuing Care Plan Transmitted - Adolescent (13 through 17 years)
HBIPS-7d
Post Discharge Continuing Care Plan Transmitted - Adult (18 through 64 years)
HBIPS-7e
Post Discharge Continuing Care Plan Transmitted - Older Adult (>=65 years)
HF - 1
Discharge Instructions
HF - 2
Evaluation of LVS Function
HF - 3
ACEI or ARB for LVSD
IMM-1a
Pneumococcal Immunization (PPV23) - Overall Rate
IMM-1b
Pneumococcal Immunization (PPV23) - Age 65 and Older
IMM-1c
Pneumococcal Immunization (PPV23) - High Risk Populations (Age 6 through 64 years)
IMM-2
Influenza Immunization
OP-1
Median Time to Fibrinolysis
OP-16
Troponin Results for ED AMI or ED CP Patients
OP-18
Median Time from ED Arrival to ED Departure for Discharged ED Patients
OP-18a
Median Time from ED Arrival to ED Departure for Discharged ED Patients - Overall Rate
OP-18b
Median Time from ED Arrival to ED Departure for Discharged ED Patients - Reporting Measure
OP-18c
Median Time from ED Arrival to ED Departure for Discharged ED Patients - Observation Patients
OP-18d
Median Time from ED Arrival to ED Departure for Discharged ED Patients - Psychiatric/Mental Health Patients
OP-18e
Median Time from ED Arrival to ED Departure for Discharged ED Patients - Transfer Patients
OP-19
Transition Record with Specified Elements Received by Discharged Patients
OP-2
Fibrinolytic Therapy Received Within 30 Minutes of ED Arrival
OP-20
Door to Diagnostic Evaluation by a Qualified Medical Personnel
OP-21
Hospital Outpatient Pain Management Population
OP-23
Head CT or MRI Scan Results for Acute Ischemic Stroke or Hemorrhagic Stroke
OP-3a
Median Time to Transfer to Another Facility for Acute Coronary Intervention - Overall Rate
OP-3b
Median Time to Transfer to Another Facility for Acute Coronary Intervention - Reporting Measure
OP-3c
Median Time to Transfer to Another Facility for Acute Coronary Intervention - Quality Measure
OP-4
Aspirin at Arrival
OP-4b
Aspirin at Arrival - AMI
OP-4c
Aspirin at Arrival - Chest Pain
OP-5
Median Time to ECG
OP-5b
Median Time to ECG - AMI
OP-5c
Median Time to ECG - Chest Pain
OP-6
Timing of Antibiotic Prophylaxis
OP-7
Prophylactic Antibiotic Selection for Surgical Patients
PC - AMI
Perfect Care - AMI
PC - CAC
Perfect Care - CAC
PC - HBIPS
Perfect Care - HBIPS
PC - HF
Perfect Care - HF
PC - IMM
Perfect Care - Immunization
PC - PCB
Perfect Care - PC B
PC - PCM
Perfect Care - PC M
PC - PN
Perfect Care - PN
PC - SCIP
Perfect Care - SCIP
PC - STK
Perfect Care - STK
PC - VTE
Perfect Care - VTE
PC-OP AMI
Perfect Care - OP AMI
PC-OP CP
Perfect Care - OP CP
PC-OP ED
Perfect Care - OP ED
PC-OP STK
Perfect Care - OP STK
PC-OP Surgical
Perfect Care - OP Surgical
PCB-04
Health Care-Associated BSI in Newborns
PCB-05
Exclusive Breast Milk Feeding
PCM-01
Elective Delivery
PCM-02a
Cesarean Section
PCM-02b
Cesarean Section - 8 through 14 years
PCM-02c
Cesarean Section - 15 through 19 years
PCM-02d
Cesarean Section - 20 through 24 years
PCM-02e
Cesarean Section - 25 through 29 years
PCM-02f
Cesarean Section - 30 through 34 years
PCM-02g
Cesarean Section - 35 through 39 years
PCM-02h
Cesarean Section - 40 through 44 years
PCM-02i
Cesarean Section - 45 through 64 years
PCM-03
Antenatal Steroids
PN - 3a
Blood Cultures Performed Within 24 Hours Prior to or 24 Hours After Hospital Arrival for Patients Who Were Transferred or Admitted to the ICU Within 24 Hours of Hospital Arrival
PN - 3b
Blood Culture in Emergency Department Before First Antibiotic
PN - 6
Initial Antibiotic Selection for CAP in Immunocompetent Patient
PN - 6a
Initial Antibiotic Selection for CAP in Immunocompetent - ICU Patient
PN - 6b
Initial Antibiotic Selection for CAP Immunocompetent - Non ICU Patient
SCIP-Card-2
Patients on Beta Blockers PTA Who Received Beta Blockers Perioperatively
SCIP-Inf - 10
Surgery Patients with Perioperative Temperature Management
SCIP-Inf - 1a
Prophylactic Antibiotic Start Within 1 Hour - Overall Rate
SCIP-Inf - 1b
Prophylactic Antibiotic Start Within 1 Hour - CABG
SCIP-Inf - 1c
Prophylactic Antibiotic Start Within 1 Hour - Other Cardiac Surgery
SCIP-Inf - 1d
Prophylactic Antibiotic Start Within 1 Hour - Hip Arthroplasty
SCIP-Inf - 1e
Prophylactic Antibiotic Start Within 1 Hour - Knee Arthroplasty
SCIP-Inf - 1f
Prophylactic Antibiotic Start Within 1 Hour - Colon Surgery
SCIP-Inf - 1g
Prophylactic Antibiotic Start Within 1 Hour - Hysterectomy
SCIP-Inf - 1h
Prophylactic Antibiotic Start Within 1 Hour - Vascular Surgery
SCIP-Inf - 2a
Prophylactic Antibiotic Selection for Surgical Patients - Overall Rate
SCIP-Inf - 2b
Prophylactic Antibiotic Selection for Surgical Patients - CABG
SCIP-Inf - 2c
Prophylactic Antibiotic Selection for Surgical Patients - Other Cardiac Surgery
SCIP-Inf - 2d
Prophylactic Antibiotic Selection for Surgical Patients - Hip Arthroplasty
SCIP-Inf - 2e
Prophylactic Antibiotic Selection for Surgical Patients - Knee Arthroplasty
SCIP-Inf - 2f
Prophylactic Antibiotic Selection for Surgical Patients - Colon Surgery
SCIP-Inf - 2g
Prophylactic Antibiotic Selection for Surgical Patients - Hysterectomy
SCIP-Inf - 2h
Prophylactic Antibiotic Selection for Surgical Patients - Vascular Surgery
SCIP-Inf - 3a
Prophylactic Antibiotics End Within 24 Hours - Overall Rate
SCIP-Inf - 3b
Prophylactic Antibiotics End Within 48 Hours - CABG
SCIP-Inf - 3c
Prophylactic Antibiotics End Within 48 Hours - Other Cardiac Surgery
SCIP-Inf - 3d
Prophylactic Antibiotics End Within 24 Hours - Hip Arthroplasty
SCIP-Inf - 3e
Prophylactic Antibiotics End Within 24 Hours - Knee Arthroplasty
SCIP-Inf - 3f
Prophylactic Antibiotics End Within 24 Hours - Colon Surgery
SCIP-Inf - 3g
Prophylactic Antibiotics End Within 24 Hours - Hysterectomy
SCIP-Inf - 3h
Prophylactic Antibiotics End Within 24 Hours - Vascular Surgery
SCIP-Inf - 4
Cardiac Surgery Patients with Controlled Postoperative Glucose
SCIP-Inf - 6
Surgery Patients with Appropriate Hair Removal
SCIP-Inf - 9
Patients with urinary catheter removed on POD1 or POD2
SCIP-VTE-1
Patients with Recommended VTE Prophylaxis Ordered
SCIP-VTE-2
Patients Receiving VTE Prophylaxis within 24 Hours Prior to or After Surgery
STK-1
Venous Thromboembolism (VTE) Prophylaxis
STK-10
Assessed for Rehabilitation
STK-2
Discharged on Antithrombotic Therapy
STK-3
Anticoagulation Therapy for Atrial Fibrillation/Flutter
STK-4
Thrombolytic Therapy
STK-5
Antithrombotic Therapy By End of Hospital Day 2
STK-6
Discharged on Statin Medication
STK-8
Stroke Education
SUB ICD-9
Substance Abuse ICD-9 Population
SUB-1
Alcohol Use Screening
SUB-2
Alcohol Use Brief Intervention Provided or Offered
SUB-2a
Alcohol Use Brief Intervention
SUB-3
Alcohol and Other Drug Use Disorder Treatment Provided or Offered at Discharge
SUB-3a
Alcohol and Other Drug Use Disorder Treatment at Discharge
SUB-4
Alcohol and Drug Use: Assessing Status After Discharge
TOB ICD-9
Tobacco Use ICD-9 Population
TOB-1
Tobacco Use Screening
TOB-2
Tobacco Use Treatment Provided or Offered
TOB-2a
Tobacco Use Treatment
TOB-3
Tobacco Use Treatment Provided or Offered at Discharge
TOB-3a
Tobacco Use Treatment at Discharge
TOB-4
Tobacco Use: Assessing Status after Discharge
VTE-1
Venous Thromboembolism Prophylaxis
VTE-2
Intensive Care Unit Venous Thromboembolism Prophylaxis
VTE-3
Venous Thromboembolism Patients with Anticoagulation Overlap Therapy
VTE-4
Venous Thromboembolism Patients Receiving Unfractionated Heparin with Dosages/Platelet Count Monitoring by Protocol
VTE-5
Venous Thromboembolism Discharge Instructions
VTE-6
Incidence of Potentially-Preventable Venous Thromboembolism
AHRQ
Agency for Healthcare Research and Quality
AMI
Acute Myocardial Infarction
CAC
Children’s Asthma Care
ED
Emergency Department
HBIPS
Hospital-Based Inpatient Psychiatric Services
HF
Heart Failure
MIF
Measure Information Form
PN
Pneumonia
SCIP
Surgical Care Improvement Project
STK
Stroke
VTE
Venous Thromboembolism